Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 120

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 120
---
     |   |       |     |     |      2023 |     |   |       |
|:---------------|:----|:--------------------------------|----------:|:----|:--|------:|:----|:----|----------:|:----|:--|------:|
|                |     | US$                             |           |     | % |       |     | US$ |           |     | % |       |
| HK SAR         |     |                                 |         - |     |   |     - |     |     |    34,038 |     |   |   0.7 |
| Kyrgyzstan     |     |                                 | 2,656,596 |     |   |  48.9 |     |     | 3,123,593 |     |   |  60.8 |
| Cambodia       |     |                                 |   601,526 |     |   |  11.1 |     |     |   621,619 |     |   |  12.1 |
| Thailand       |     |                                 | 2,175,253 |     |   |  40.0 |     |     | 1,356,903 |     |   |  26.4 |
| Total revenues |     |                                 | 5,433,375 |     |   | 100.0 |     |     | 5,136,153 |     |   | 100.0 |

NewGenIvf’s revenue
results are affected by, among others, changes in sales price and the fluctuation of foreign currency rates with US dollars. A 5% change
in sales price would cause 5% change in NewGenIvf’s revenue. Based on the breakdown of the revenue contribution in terms of currencies
used by customers for 2024, a 5% change in foreign currency rates with US dollars would cause approximately 2.4% change in NewGenIvf’s
revenue.

<div align='center'>66</div>

IVF treatment services

NewGenIvf generated revenue
from IVF treatment services provided at facilities that NewGenIvf operated in Thailand and Cambodia. In addition, NewGenIvf also recognized
revenues from IVF treatments included in surrogacy services performed in Kyrgyzstan. NewGenIvf’s revenue from IVF treatment service
amounted to US$5,433,375 and US$4